Stocks and Investing
Stocks and Investing
Fri, October 13, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Maintained (ATXS) at Buy with Decreased Target to $18 on, Oct 13th, 2023
Laura Chico of Wedbush, Maintained "Astria Therapeutics, Inc." (ATXS) at Buy with Decreased Target from $25 to $18 on, Oct 13th, 2023.
Laura has made no other calls on ATXS in the last 4 months.
There is 1 other peer that has a rating on ATXS. Out of the 1 peers that are also analyzing ATXS, 0 agree with Laura's Rating of Hold.
This is the rating of the analyst that currently disagrees with Laura
- Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Thursday, October 12th, 2023
Contributing Sources